clinical trial · NCT04089059
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
Endotronix, Inc.·N/A·active not recruiting·n = 738
Heart Failure NYHA Class IIICordella™ Pulmonary Artery Sensor System
brief summary
This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients compared to a Performance Goal (PG).
started
Jan 10, 2020
primary completion
Apr 1, 2028
completion
Apr 1, 2028
last updated
Mar 3, 2025
official title
A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol